Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-056779

Co-Chief Executive Officer gave up 588 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 1,563 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WEST MICHAEL D Co-Chief Executive Officer 2017-10-10 Option exercise +1,563 884,427 D
WEST MICHAEL D Co-Chief Executive Officer 2017-10-10 Shares withheld for taxes −588 $2.81 $1,652 883,839 D
Derivatives
WEST MICHAEL D Co-Chief Executive Officer 2017-10-10 Option exercise · Restricted Stock Units −1,563 15,625 D
Loading xslF345X03/doc4.xml…